Updates are available Correction dated 2018-04-09

Article History

First Online: 19 March 2018

Change Date: 9 April 2018

Change Type: Correction

Change Details: In the March 2018 issue of Current Hypertension Reports, the second author’s name Nathan A. Sobotka was inadvertently left out of the byline. Also, the author names were changed from initials to spelled out. The corrected author list is given above. The original article has been corrected.

Compliance with Ethical Standards

:

: Dr. Stefan Bertog has received reimbursement for travel expenses or study honoraria from Ablative Solutions, Johnson and Johnson, and Medtronic.Nathan Sobotka is a member of Paul Sobotka’s immediate family.Dr. Paul Sobotka is chief medical officer of ROX Medical Inc. with both salary and stock.Dr. Melvin Lobo reports personal fees from ROX Medical during the conduct of the study and personal fees from CVRx, personal fees from Cardiosonic, personal fees from St Jude Medical, and personal fees from KONA Medical, outside the submitted work.Dr. Kolja Sievert has nothing to disclose.Laura Vaskelyte has nothing to disclose.Dr. Horst Sievert has received consulting fees, reimbursement for travel expenses or study honoraria from the following companies: Abbott, Ablative Solutions, Ancona Heart, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, Celonova, Cibiem, CGuard, Comed B.V., Contego, CVRx, Edwards, Gardia, Hemoteq, InspireMD, Kona Medical, Lifetech, Maquet Getinge Group, Medtronic, Occlutech, pfm Medical, Recor, St. Jude Medical, Terumo, Trivascular, Vascular Dynamics, Venus, and Veryan.Schmieder RE reports grants from Rox Medical to the institution, outside the submitted work.

: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).